Sigma Of Australia Gets New Buyout Offer 7 Percent Lower Than First
This article was originally published in PharmAsia News
Executive Summary
Australia's Sigma Pharmaceuticals said Aspen Pharmacare Holdings has reduced its acquisition offer from U.S.$589 million to U.S.$549 million